Sort
40,608 grants matching “prostate cancer”
Commercializing Praedicare Dx TM platform for guiding cancer treatments
$998,807Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2017 · CA
Illinois Oncology Research Association Community Clinical Oncology Program
$998,654John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2009 · CA
Fast Acousto-Optic Tomography System
$998,456Paul Shnitser · Physical Optics Corporation · R44 · FY2010 · CA
Enhancing Primary Care Capacity for Cancer Survivorship Care Delivery in Community Health Clinics
$998,444Bijal A. Balasubramanian · University Of Texas Hlth Sci Ctr Houston · U01 · FY2024 · CA
HHSN261201400050C;TOPIC 309?DEVELOPMENT OF LOW COST, SMALL SAMPLE MULTI-ANALYTE TECH. FOR CANCER DIAGNOSIS,PROGNOSIS&EARLY DETECTION?;TITLE:HIGHLY SENSITIVE AND SPECIFIC MULTIPLEX PROSTATE CANCER ASSA
$998,411Wlodek Mandecki · Pharmaseq, Inc. · N44 · FY2014 · CA
Howard/Hopkins Cancer Centers Partnership
$998,376William G Nelson · Johns Hopkins University · U54 · FY2007 · CA
INFLAMMATORY PROCESSES, EMOTION REGULATION, AND DEPRESSION IN PROSTATE CANCER SURVIVORS
$998,182University Of California Irvine · · FY2020 · Defense Health Agency
Leadership, Planning and Evaluation
$997,983Alan Ashworth · University Of California, San Francisco · P30 · FY2024 · CA
MOUSE CANCER MODELS VIA TGF-BETA RII LOSS
$997,931Vanderbilt University · U01 · FY2002 · CA
Leadership, Planning and Evaluation
$997,892Alan Ashworth · University Of California, San Francisco · P30 · FY2023 · CA
ACHIEVING BETTER CANCER DIAGNOSIS (ABCD): Identifying, supporting, and learning from marginalized patients who experience delayed cancer diagnosis
$996,882Gordon David Schiff · Brigham And Women'S Hospital · R18 · FY2022 · HS
Identification of Master Regulators for stem cell pluripotency and self-renewal
$996,817Michael M. Shen · Columbia University Health Sciences · RC1 · FY2010 · GM
Prostate Cancer Studies
$995,563Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Spectroscopic Localization of Breast Cancer
$995,474David A. Benaron · Spectros Corporation · R44 · FY2007 · CA
Urine Diagnostic Tool for the Detection of High-grade Prostate Cancer
$995,327Yashar Sharifi Niknafs · Lynx Dx, Inc. · R44 · FY2021 · CA
Center for Interventional Oncology
$995,007Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2010 · CA
Rapid Identification of Pathogenic Bacteria and Sepsis Diagnosis
$994,871Ray Anthony Martino · Isense, Llc · R44 · FY2013 · AI
Leadership, Planning and Evaluation
$994,847Caryn Lerman · University Of Southern California · P30 · FY2023 · CA
Providing GMP-grade Terbium-161 as a therapeutic option for US academic institution
$994,810Ian Horvath · Fusion Energy Solutions, Inc. D/B/A Serva Energy · R44 · FY2025 · CA
3D Spatial Biology of Prostate Cancer Biopsies For Earlier Identification of High Risk Patients
$994,370Nicholas Reder · Alpenglow Biosciences, Inc. · R44 · FY2024 · CA
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
$994,198Romonia Renee Reams · Florida Agricultural And Mechanical Univ · U54 · FY2022 · CA
DECODE: Diagnostic Excellence Center on Diagnostic Error
$994,129Ramin Khorasani · Brigham And Women'S Hospital · R18 · FY2023 · HS
DECODE: Diagnostic Excellence Center on Diagnostic Error
$994,128Ramin Khorasani · Brigham And Women'S Hospital · R18 · FY2025 · HS
Enabling clinical tissue microstructure imaging as a diagnostic tool in wide-bore 3T MRI
$993,663Thomas K Foo · Ge Medical Systems Information Technologies, Inc · U01 · FY2024 · EB
PCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research
$993,421Catherine M. Tangen · Fred Hutchinson Cancer Research Center · UM1 · FY2015 · CA